Healthcare -
Biotechnology - NASDAQ - US
$ 1.565
7.19 %
$ 101 M
Market Cap
-1.01
P/E
INZY - OPERATING EXPENSES
Operating Expenses INZY - Inozyme Pharma, Inc.
75.6 M
LAST VALUE
15.56%
2 YEAR CAGR
45.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR